The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Antzeko izenburuak

• The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
  nork: Dovedi, S J, et al.
  Argitaratua: (2015)
• Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells
  nork: Dovedi, Simon J., et al.
  Argitaratua: (2016)
• A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
  nork: Cheadle, E J, et al.
  Argitaratua: (2017)
• Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
  nork: Cheadle, E J, et al.
  Argitaratua: (2017)
• Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
  nork: Dovedi, Simon J., et al.
  Argitaratua: (2016)